Biophotonics Market by Medical Applications (Bioimaging, Bioassays, Optical Biosensors and Biochips, Medical Devices), Non-Medical Applications (Biometric and Biosensing Devices, Uv Sterilization Equipment), and Regions – Global Forecast To 2020

The overall market for biophotonics in 2014 was valued at USD 26.26 Billion, which is estimated to reach USD 50.18 Billion by 2020, at a CAGR of 11.5% during the forecast period. This market growth can be attributed to emergence of nanotechnology, significant technological advancements over the last few years and their adoption in the medical sector, increase in the demand for home-based POC devices, aging population, and growing lifestyle diseases. The report categorizes the global biophotonics market on the basis of application, technology, end use, and geography as well as forecasts the market size and analyzes trends in the said market. This report is focused on giving a bird’s eye-view of the market with regards to the qualitative analysis at each and every aspect of the classification done. The report provides a forecast of the growth of the biophotonics market between 2015 and 2020.

This research study involves extensive usage of secondary sources, directories, and databases (such as Hoovers, Bloomberg, Businessweek, Factiva, and OneSource) to identify and collect information useful for this technical, market-oriented, and commercial aspects of biophotonics market. In addition to secondary sources, the market data was collected by primary research as well by conducting extensive interviews with key people such as CEOs, VPs, Directors and executives. After arriving at the overall market size the total market has been split into several segments and sub-segments. The figure below shows the break-down of the primaries on the basis of company, designation, and region, conducted during the research study.

This report takes a close look at the biophotonics market, providing a holistic outlook on market dynamics, industry trends, and supply & demand. The study aims at providing granular information regarding estimates and forecasts for the biophotonics market segments. This report is based on an extensive research study of the biophotonics market and aims at identifying the entire market and all its sub-segments through extensively detailed classifications. The demand for biophotonics is expected to grow significantly and gain importance among players across various domains. The Americas is projected to be the fastest-growing market during the forecast period.

The information provided in this report includes profiles of leading companies in the biophotonics ecosystem, key developments, core strategies deployed by various players, mergers and acquisitions, new product developments, collaborations, and joint ventures of key manufacturers along with their financials. A competitive landscape of the current market has been analyzed on the basis of a company’s recent developments, R&D activities, and product portfolio among other factors.

The target audience of the report include existing players in biophotonics market, start-up companies, venture capitalists, private equity groups, investment houses, equity research firms and other stakeholders. This study answers several questions for the stakeholders, primarily which market segments to focus in next two to five years for prioritizing the efforts and investments.

The report also discusses the future of the global market with roadmaps, upcoming technologies, and applications with respect to biophotonics market. Key players in this industry include, Affymetrix, Inc. (U.S.), Andor Technology Ltd. (U.K.), Becton, Dickinson and Company (U.S.), Carl Zeiss AG (Germany), FEI Company (U.S.), Hamamatsu Photonics K.K. (Japan), Lumenis Ltd. (Israel), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), and Zecotek Photonics Inc. (Canada).